Common variation in genes involved in HDL metabolism influences coronary heart disease risk at the population level

被引：5

作者：

Brousseau, ME ^{[1
]}

机构：

[1] Tufts Univ, Lipid Metab Lab, JM USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA

[2] Tufts Univ New England Med Ctr, Dept Med, Boston, MA 02111 USA

来源：

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS | 2004年 / 5卷 / 04期

关键词：

ATP-binding cassette transporter A1; cholesteryl ester transfer protein; high density lipoproteins; polymorphism;

D O I：

10.1023/B:REMD.0000045106.90301.26

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The majority of data support the concept that common variation in the genes encoding ABCA1 and CETP is associated with variation in plasma HDL-C concentrations and/or CHD risk at the population level. Polymorphisms in ABCA1, in particular the R219K variant, appear to influence CHD risk, independent of plasma HDL-C levels. In contrast, CETP polymorphisms that are generally associated with reduced CHD risk, such as the TaqIB variant, are also associated with increased HDL-C levels.

引用

页码：343 / 349

页数：7

共 47 条

[1] Cholesteryl ester transfer protein - A novel target for raising HDL and inhibiting atherosclerosis [J].

Barter, PJ ;

Brewer, HB ;

Chapman, MJ ;

Hennekens, CH ;

Rader, DJ ;

Tall, AR .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :160-167

[2] Unique lipoprotein phenotype and genotype associated with exceptional longevity [J].

Barzilai, N ;

Atzmon, G ;

Schechter, C ;

Schaefer, EJ ;

Cupples, AL ;

Lipton, R ;

Cheng, S ;

Shuldiner, AR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15) :2030-2040

[3] Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease [J].

Blankenberg, S ;

Rupprecht, HJ ;

Bickel, C ;

Jiang, XC ;

Poirier, O ;

Lackner, KJ ;

Meyer, J ;

Cambien, F ;

Tiret, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) :1983-1989

[4] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].

Bodzioch, M ;

Orsó, E ;

Klucken, T ;

Langmann, T ;

Böttcher, L ;

Diederich, W ;

Drobnik, W ;

Barlage, S ;

Büchler, C ;

Porsch-Özcürümez, M ;

Kaminski, WE ;

Hahmann, HW ;

Oette, K ;

Rothe, G ;

Aslanidis, C ;

Lackner, KJ ;

Schmitz, G .

NATURE GENETICS, 1999, 22 (04) :347-351

[5] Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease [J].

Boekholdt, SM ;

Thompson, JF .

JOURNAL OF LIPID RESEARCH, 2003, 44 (06) :1080-1093

[6] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].

Brooks-Wilson, A ;

Marcil, M ;

Clee, SM ;

Zhang, LH ;

Roomp, K ;

van Dam, M ;

Yu, L ;

Brewer, C ;

Collins, JA ;

Molhuizen, HOF ;

Loubser, O ;

Ouelette, BFF ;

Fichter, K ;

Ashbourne-Excoffon, KJD ;

Sensen, CW ;

Scherer, S ;

Mott, S ;

Denis, M ;

Martindale, D ;

Frohlich, J ;

Morgan, K ;

Koop, B ;

Pimstone, S ;

Kastelein, JJP ;

Genest, J ;

Hayden, MR .

NATURE GENETICS, 1999, 22 (04) :336-345

[7] Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency -: Veterans Affairs HDL Cholesterol Intervention Trial [J].

Brousseau, ME ;

O'Connor, JJ ;

Ordovas, JM ;

Collins, D ;

Otvos, JD ;

Massov, T ;

McNamara, JR ;

Rubins, HB ;

Robins, SJ ;

Schaefer, EJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (07) :1148-1154

[8] Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease [J].

Brousseau, ME ;

Bodzioch, M ;

Schaefer, EJ ;

Goldkamp, AL ;

Kielar, D ;

Probst, M ;

Ordovas, JM ;

Aslanidis, C ;

Lackner, KJ ;

Rubins, HB ;

Collins, D ;

Robins, SJ ;

Wilson, PWF ;

Schmitz, G .

ATHEROSCLEROSIS, 2001, 154 (03) :607-611

[9]

Brousseau ME, 2000, J LIPID RES, V41, P433

[10] The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease [J].

Carlquist, JF ;

Muhlestein, JB ;

Horne, BD ;

Hart, NI ;

Bair, TL ;

Molhuizen, HOF ;

Anderson, JL .

AMERICAN HEART JOURNAL, 2003, 146 (06) :1007-1014

← 1 2 3 4 5 →